liposomal glutathione parkinson& 39 Astaxanthin-loaded brain-permeable liposomes for Parkinson's disease treatment via antioxidant and anti-inflammatory responses Dual-pathway targeted therapy for Parkinson's
Dual pathway targeted therapy for Parkinson's disease: Biomimetic nanosomes inhibit ferroptosis and pyroptosis through NLRP3 inflammasome regulation ScienceDirect Neurotransmitter Dysregulation in Parkinson's Disease: Pathophysiological Insights and Therapeutic Perspectives PMC Recent advances in therapeutic strategies for Alzheimer's and Parkinson's disease using protein peptide co modified polymer nanoparticles Neuroprotection Levodopa and PlantDerived Bioactive Compounds in Parkinson's Disease: Mechanisms, Efficacy, and Future Perspectives PMC
Pay in 4 interest-free payments of $6.43 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16



